Search research articles
Contact Us
Filters
Showing results (441-450 of 574) with videos related to
Page
of 58
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 22, 2008
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics
C Warren Olanow, Robert A Hauser, Joseph Jankovic, et al.
Neurology
|
January 31, 2024
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Toxins
|
May 26, 2023
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
American Journal of Clinical Pathology
|
March 18, 2008
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang, Izabela Sokal, Elaine R Peskind, et al.
Parkinsonism & Related Disorders
|
April 17, 2007
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease
L Warren, R Gibson, L Ishihara, et al.
European Journal of Neurology
|
March 17, 2021
Worldwide barriers to genetic testing for movement disorders
Emilia M Gatto, Ruth H Walker, Claudio Gonzalez, et al.
Ebiomedicine
|
October 2, 2022
Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology
Lorraine N Clark, Yizhe Gao, Gao T Wang, et al.
Parkinsonism & Related Disorders
|
August 18, 2019
Hypertension and progressive supranuclear palsy
Soniya V Rabadia, Irene Litvan, Jorge Juncos, et al.
Clinical Neuropharmacology
|
June 4, 2008
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
Samuel Frank, William Ondo, Stanley Fahn, et al.
Page
of 58
Search research articles
Search
Showing results (441-450 of 574) with videos related to
Sort By:
Page
of 58
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 22, 2008
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics
C Warren Olanow, Robert A Hauser, Joseph Jankovic, et al.
Neurology
|
January 31, 2024
Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial
Cynthia L Comella, Joseph Jankovic, Robert A Hauser, et al.
JAMA Neurology
|
December 13, 2016
Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial
Anthony H V Schapira, Susan H Fox, Robert A Hauser, et al.
Toxins
|
May 26, 2023
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX<sup>®</sup>) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
American Journal of Clinical Pathology
|
March 18, 2008
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases
Jing Zhang, Izabela Sokal, Elaine R Peskind, et al.
Parkinsonism & Related Disorders
|
April 17, 2007
A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease
L Warren, R Gibson, L Ishihara, et al.
European Journal of Neurology
|
March 17, 2021
Worldwide barriers to genetic testing for movement disorders
Emilia M Gatto, Ruth H Walker, Claudio Gonzalez, et al.
Ebiomedicine
|
October 2, 2022
Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology
Lorraine N Clark, Yizhe Gao, Gao T Wang, et al.
Parkinsonism & Related Disorders
|
August 18, 2019
Hypertension and progressive supranuclear palsy
Soniya V Rabadia, Irene Litvan, Jorge Juncos, et al.
Clinical Neuropharmacology
|
June 4, 2008
A study of chorea after tetrabenazine withdrawal in patients with Huntington disease
Samuel Frank, William Ondo, Stanley Fahn, et al.
Page
of 58